XML 66 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statement of Equity - USD ($)
$ in Millions
Total
Foreign Exchange Contract [Member]
Interest Rate Swap [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings (Accumulated Deficit) [Member]
Accumulated Other Comprehensive Income Loss [Member]
Accumulated Other Comprehensive Income Loss [Member]
Foreign Exchange Contract [Member]
Accumulated Other Comprehensive Income Loss [Member]
Interest Rate Swap [Member]
Noncontrolling Interests [Member]
Beginning balance outstanding (in shares) at Dec. 31, 2018       0 143,205,394            
Balance beginning of period at Dec. 31, 2018 $ 1,431.2     $ 0.0 $ 0.0 $ 1,744.6 $ (56.4) $ (441.5)     $ 184.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Restricted stock grants (RSG) (in shares)         31,875            
Shares retired due to RSG vesting (in shares)         (250,287)            
Shares retired due to RSG vesting (5.1)         (5.1)          
Shares retired due to common stock repurchase program (in shares)         (152,252)            
Shares retired due to common stock repurchase program (2.8)       $ (2.8) (2.7) (0.1)        
Stock based compensation 10.4         10.4          
Other comprehensive (loss) income:                      
Unrealized foreign currency translation loss, net of tax (18.3)             (16.0)     (2.3)
Unrealized currency derivative contracts gain (loss)   $ 32.9             $ 32.9    
Common stock dividends (30.3)           (30.3)        
Preferred stock dividends 0.0                    
Net income 1.6           (5.3)       6.9
Contributions from noncontrolling interests 5.3                   5.3
Distributions to noncontrolling interests (122.7)                   (122.7)
Ending balance outstanding (in shares) at Mar. 31, 2019       0 142,834,730            
Balance end of period at Mar. 31, 2019 1,302.2     $ 0.0 $ 0.0 1,747.2 (92.1) (424.6)     71.7
Beginning balance outstanding (in shares) at Dec. 31, 2019       300,000 142,283,109            
Balance beginning of period at Dec. 31, 2019 1,719.2     $ 295.2 $ 0.0 1,754.5 46.2 (417.2)     40.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Restricted stock grants (RSG) (in shares)         2,533,967            
Shares retired due to RSG vesting (in shares)         (409,716)            
Shares retired due to RSG vesting (9.1)         (9.1)          
Shares retired due to common stock repurchase program (in shares)         (858,496)            
Shares retired due to common stock repurchase program         $ (16.6) (15.3) (1.3)        
Stock based compensation 8.6         8.6          
Other comprehensive (loss) income:                      
Unrealized foreign currency translation loss, net of tax (16.5)             (15.0)     (1.5)
Unrealized currency derivative contracts gain (loss)   $ 13.0 $ (5.6)           $ 13.0 $ (5.6)  
Common stock dividends (31.6)           (31.6)        
Preferred stock dividends (4.3)           (4.3)        
Net income (5.9)           (5.6)       (0.3)
Contributions from noncontrolling interests 0.3                   0.3
Distributions to noncontrolling interests (0.2)                   (0.2)
KW Europe Fund II deconsolidation 3.7                   3.7
Ending balance outstanding (in shares) at Mar. 31, 2020       300,000 143,548,864            
Balance end of period at Mar. 31, 2020 $ 1,655.0     $ 295.2 $ 0.0 $ 1,738.7 $ 3.4 $ (424.8)     $ 42.5